Tocilizumab in addition to standard of care in the management of COVID-19: a meta-analysis of RCTs

OBJECTIVE: We performed a systematic review and meta-analysis for exploring clinical benefits and safety of tocilizumab in addition to standard of care (SOC) in treating patients with coronavirus disease 2019 (COVID-19). METHODS: An electronic search was carried out in PubMed, EMBASE, Cochrane Libra...

Descripción completa

Detalles Bibliográficos
Autores principales: Mutua, Victor, Henry, Brandon Michael, von Csefalvay, Chris, Cheruiyot, Isaac, Vikse, Jens, Lippi, Giuseppe, Bundi, Brian, Mong’are, Newnex
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mattioli 1885 2022
Materias:
Reviews/Focus on
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8972884/
https://www.ncbi.nlm.nih.gov/pubmed/35315395
http://dx.doi.org/10.23750/abm.v93i1.12208

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8972884/
https://www.ncbi.nlm.nih.gov/pubmed/35315395
http://dx.doi.org/10.23750/abm.v93i1.12208

Ejemplares similares